Biotechnology News PEGINTRON Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-3 out of 3 found

Current Search: pegintron: 3

Abacavir (Ziagen) Does Not Compromise Effectiveness of Hepatitis C Treatment, but Zidovudine (Retrovir) May Re
The effect of accompanying antiretroviral drugs on virological response to hepatitis C therapy using remains uncertain, given that prior studies have produced conflicting results.

Like ribavirin, zidovudine can cause anemia, which may increase the risk of...

HIV and Hepatitis.com: Mar 2 2010 1:10AM
Matching: pegintron

Find similar documents

Is One Type of Pegylated Interferon More Effective for Treating Chronic Hepatitis C?
is standard therapy for chronic hepatitis C, but there has not been consensus about the relative benefits of Pegasys (Roche/Genentech) and PegInton (Schering-Plough).

Past research has produced conflicting findings, and data have not always been strictly...

HIV and Hepatitis.com: Feb 12 2010 12:18AM
Matching: pegintron

Find similar documents

Human Genome calls hepatitis drug sleeper product
Human Genome Sciences Inc is awaiting a US approval decision later this year for Zalbin, an interferon that would compete with Roche Holding AGs big-selling Pegasys and Merck & Cos Inc Pegintron.

The two current leading interferons are taken...

Times Live South Africa: Feb 10 2010 12:53PM
Matching: pegintron

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.